Related Experiment Video
Updated: Jan 6, 2026
05:17
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
1.9K
Structural Modification of Heterocyclic Scaffolds: A Strategy for Antibacterial Drug Discovery
Raksha Gupta1, Anubhuti Koshle1, Santosh Kumar Verma2
1Department of Chemistry, Shri Rawatpura Sarkar University, Raipur, Chhattisgarh, India.
Archiv Der Pharmazie
|November 3, 2025
Summary
Novel electron-withdrawing groups (EWGs) show promise in enhancing antibiotic effectiveness against multidrug-resistant bacteria like MRSA. This research explores their role in developing new antibacterial drugs to combat rising infections.
Area of Science:
- Medicinal Chemistry
- Bacteriology
- Drug Discovery
Background:
- Multidrug-resistant (MDR) bacterial infections, particularly Methicillin-resistant Staphylococcus aureus (MRSA), pose a significant global health threat.
- MRSA exhibits rapid resistance evolution to existing antibiotics, including vancomycin, necessitating the development of novel therapeutic agents.
- There is a critical need for new, effective, and safer antibiotics to combat challenging bacterial pathogens.
Purpose of the Study:
- To review the potential benefits of incorporating electron-withdrawing groups (EWGs) in medicinal chemistry for antibacterial drug discovery.
- To explore how EWGs can enhance the efficacy and pharmacokinetic properties of potential antibiotic candidates against bacterial pathogens.
- To highlight the strategic use of EWGs in developing novel treatments for multidrug-resistant bacterial infections.
Main Methods:
- Literature review focusing on the role of electron-withdrawing groups (EWGs) in medicinal chemistry.
- Analysis of how EWGs influence physicochemical and pharmacokinetic properties of small molecules.
- Examination of studies demonstrating EWGs' impact on antibacterial activity against various pathogens.
Main Results:
- Electron-withdrawing groups (EWGs), such as -Cl, NO2, F, and Br, can significantly improve the antibacterial effectiveness of drug candidates.
- Strategic placement of EWGs can enhance crucial properties like membrane permeability and metabolic stability, vital for combating MRSA.
- The review indicates a strong potential for EWGs in overcoming bacterial resistance mechanisms.
Conclusions:
- Electron-withdrawing groups (EWGs) represent a promising strategy for enhancing antibacterial potency and overcoming resistance in drug discovery.
- The targeted application of EWGs can lead to the development of more effective and stable antimicrobial agents against challenging infections.
- Further research into EWG-modified compounds is warranted for the development of next-generation antibiotics to combat MDR bacteria.
More Related Videos
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
01:13Five-Membered Heterocyclic Aromatic Compounds: Overview
5.2K
Heterocyclic aromatic compounds are cyclic compounds that are aromatic and have one or more heteroatoms—atoms other than carbon, in the ring. Depending upon the number of atoms present in the ring, they can be either five or six-membered. Examples of five-membered heterocyclic aromatic compounds include pyrrole, furan, thiophene, and imidazole. Pyrrole consists of one nitrogen atom having one lone pair of electrons. Furan and thiophene have one oxygen and one sulfur heteroatom,...
5.2K
01:29Diels–Alder Reaction Forming Bridged Bicyclic Products: Stereochemistry
5.3K
Diels–Alder reactions between cyclic dienes locked in an s-cis configuration and dienophiles yield bridged bicyclic products.
5.3K
01:10Nomenclature of Aryl and Heterocyclic Amines
3.0K
The simplest aromatic amine is phenylamine, which contains an –NH2 functionality directly attached to an aromatic ring. The name aniline is designated for this skeleton. As shown in Figure 1, the common names of the functionalized anilines involve prefixes ortho-, meta-, and para- to indicate the substitution position. Different functionalized aniline derivatives also have notable trivial names.
3.0K
01:25Basicity of Heterocyclic Aromatic Amines
6.8K
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
6.8K
01:26Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K